Amgen Inc.
AMGN
$273.94
-$2.44-0.88%
Headlines
4/30/2024
-
Ticker Report
4/30/2024
-
Ticker Report
4/30/2024
-
BizJournals.com - Nat'l Business News
4/30/2024
-
Insider Monkey
4/30/2024
-
Benzinga
4/30/2024
-
Ticker Report
4/30/2024
-
Zacks Investment Research
4/30/2024
-
The Fly
4/30/2024
-
The Fly
4/30/2024
-
Seeking Alpha - Healthcare
4/29/2024
-
Ticker Report
4/29/2024
-
PR Newswire
4/29/2024
-
SeekingAlpha.com: All News
4/29/2024
-
Seeking Alpha - Healthcare
4/29/2024
-
Zacks Investment Research
4/29/2024
-
Zacks Investment Research
4/29/2024
-
Dividend Channel
4/29/2024
-
ETF Channel
4/29/2024
-
Zacks Investment Research
4/29/2024
-
Zacks Investment Research
4/29/2024
-
Ticker Report
4/28/2024
-
Ticker Report
4/28/2024
-
Investopedia Headlines
4/28/2024
-
TheStreet.com
4/27/2024
-
Seeking Alpha - Healthcare
Filings
Wednesday, February 14, 2024
Sunday, December 31, 2023
Week of Apr 22 and 26 (est)
Price History
Corporate Info
805 447 1000
One Amgen Center Drive
Thousand Oaks, CA 91320-1799
Thousand Oaks, CA 91320-1799
Business Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company’s principal products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and...
more